Technical Analysis for ACHV - Achieve Life Sciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Slingshot Bullish | Bullish Swing Setup | -3.30% | |
NR7 | Range Contraction | -3.30% | |
Upper Bollinger Band Walk | Strength | -3.30% | |
Overbought Stochastic | Strength | -3.30% | |
Gapped Down | Weakness | -3.30% | |
Bearish Engulfing | Bearish | -4.64% | |
Upper Bollinger Band Walk | Strength | -4.64% | |
Outside Day | Range Expansion | -4.64% | |
Gapped Up | Strength | -4.64% | |
Overbought Stochastic | Strength | -4.64% |
Alert | Time |
---|---|
Gapped Down (Partial) | about 4 hours ago |
Down 3% | about 4 hours ago |
Fell Below Previous Day's Low | about 4 hours ago |
Down 2 % | about 4 hours ago |
Down 1% | about 4 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 8.37 |
52 Week Low | 3.03 |
Average Volume | 107,835 |
200-Day Moving Average | 4.53 |
50-Day Moving Average | 4.57 |
20-Day Moving Average | 4.69 |
10-Day Moving Average | 4.82 |
Average True Range | 0.24 |
RSI (14) | 60.32 |
ADX | 12.41 |
+DI | 24.31 |
-DI | 17.94 |
Chandelier Exit (Long, 3 ATRs) | 4.64 |
Chandelier Exit (Short, 3 ATRs) | 5.07 |
Upper Bollinger Bands | 5.13 |
Lower Bollinger Band | 4.25 |
Percent B (%b) | 0.85 |
BandWidth | 18.77 |
MACD Line | 0.14 |
MACD Signal Line | 0.09 |
MACD Histogram | 0.0486 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.26 | ||||
Resistance 3 (R3) | 5.25 | 5.17 | 5.21 | ||
Resistance 2 (R2) | 5.17 | 5.10 | 5.17 | 5.20 | |
Resistance 1 (R1) | 5.08 | 5.06 | 5.04 | 5.09 | 5.18 |
Pivot Point | 5.00 | 5.00 | 4.98 | 5.00 | 5.00 |
Support 1 (S1) | 4.91 | 4.93 | 4.87 | 4.92 | 4.82 |
Support 2 (S2) | 4.83 | 4.89 | 4.83 | 4.80 | |
Support 3 (S3) | 4.74 | 4.83 | 4.79 | ||
Support 4 (S4) | 4.75 |